Related references
Note: Only part of the references are listed.Expression of CD25 independently predicts early treatment failure of acute myeloid leukaemia (AML)
Jan Cerny et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Protective and pathological roles of mast cells and basophils
David Voehringer
NATURE REVIEWS IMMUNOLOGY (2013)
CD25 expression status improves prognostic risk classification in AML independent of established biomarkers: ECOG phase 3 trial, E1900
Mithat Goenen et al.
BLOOD (2012)
Integrative Epigenomic Analysis Identifies Biomarkers and Therapeutic Targets in Adult B-Acute Lymphoblastic Leukemia
Huimin Geng et al.
CANCER DISCOVERY (2012)
Pushing the limits of targeted therapy in chronic myeloid leukaemia
Thomas O'Hare et al.
NATURE REVIEWS CANCER (2012)
IL-6 Controls Leukemic Multipotent Progenitor Cell Fate and Contributes to Chronic Myelogenous Leukemia Development
Damien Reynaud et al.
CANCER CELL (2011)
Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity
Amie S. Corbin et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Wnt/Ca2+/NFAT Signaling Maintains Survival of Ph+ Leukemia Cells upon Inhibition of Bcr-Abl
Mark A. Gregory et al.
CANCER CELL (2010)
Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial
Francois-Xavier Mahon et al.
LANCET ONCOLOGY (2010)
TGF-β-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia
Kazuhito Naka et al.
NATURE (2010)
Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein
Marcus Jaras et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Interleukin-2 receptor alpha-chain (CD25) expression on leukaemic blasts is predictive for outcome and level of residual disease in AML
Monique Terwijn et al.
EUROPEAN JOURNAL OF CANCER (2009)
Stem cell defects in ATM-deficient undifferentiated spermatogonia through DNA damage-induced cell-cycle arrest
Keiyo Takubo et al.
CELL STEM CELL (2008)
Efficient retroviral transduction of human B-lymphoid and myeloid progenitors:: marked inhibition of their growth by the Pax5 transgene
Rieko Sekine et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2008)
PML targeting eradicates quiescent leukaemia-initiating cells
Keisuke Ito et al.
NATURE (2008)
IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells
Shafaqat Ali et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Integrated signalling pathways for mast-cell activation
AM Gilfillan et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Gene expression changes associated with progression and response in chronic myeloid leukemia
JP Radich et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche
F Arai et al.
CELL (2004)
CD25 indicates the neoplastic phenotype of mast cells - A novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens
K Sotlar et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
Mechanisms of disease - Chronic myeloid leukemia - Advances in biology and new approaches to treatment
JM Goldman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Regulation of mast-cell and basophil function and survival by IgE
T Kawakami et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Share Paper
